Evidence map›Paper›PMID 19109115›Full record

ArticleJAMA2008

Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.

Dima M Qato, G Caleb Alexander, Rena M Conti, Michael Johnson, Phil Schumm, Stacy Tessler Lindau

Abstract read
In one paragraph

Article in JAMA, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 381 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
381citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

381 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Trial
  11. Trial
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

321 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dima M QatoDepartment of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA. dqato@babies.bsd.uchicago.edu
G Caleb Alexander
Rena M Conti
Michael Johnson
Phil Schumm
Stacy Tessler Lindau

Funding

National Social Life, Health and Aging Project (RMI)R01AG021487 · NIA · NATIONAL OPINION RESEARCH CENTER · PI WAITE, LINDA J · 2003 to 2007
$12.2M
PROGRAM DEVELOPMENT COREP30AG012857 · NIA · NATIONAL OPINION RESEARCH CENTER · PI WAITE, LINDA J · 1999 to 2013
$5.7M
Sexuality, Aging and Heart Disease: Translating from Population to PatientK23AG032870 · NIA · UNIVERSITY OF CHICAGO · PI LINDAU, STACY TESSLER · 2009 to 2012
$747k
An RCT To Decrease Out-Of-Pocket Prescription CostsK08HS015699 · AHRQ · UNIVERSITY OF CHICAGO · PI ALEXANDER, G. CALEB · 2006 to 2010
$617k
Pharmacy Accessibility and Disparities in Adherence to Cardiovascular Medications in ElderlyR21AG049283 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI QATO, DIMA MAZEN · 2015 to 2016
$443k
AHRQ HHS K08 HS015699AHRQ HHS K08 HS15699-01A1NIA NIH HHS 5 P30 AG 012857NIA NIH HHS 5R01AG021487NIA NIH HHS K23 AG032870NIA NIH HHS P30 AG012857NIA NIH HHS R01 AG021487NIA NIH HHS R21 AG049283
6 · The paper itself

Abstract

contextDespite concerns about drug safety, current information on older adults' use of prescription and over-the-counter medications and dietary supplements is limited.

objectiveTo estimate the prevalence and patterns of medication use among older adults (including concurrent use), and potential major drug-drug interactions. DESIGN, SETTING, AND

participantsThree thousand five community-residing individuals, aged 57 through 85 years, were drawn from a cross-sectional, nationally representative probability sample of the United States. In-home interviews, including medication logs, were administered between June 2005 and March 2006. Medication use was defined as prescription, over-the-counter, and dietary supplements used "on a regular schedule, like every day or every week." Concurrent use was defined as the regular use of at least 2 medications.

main outcome measurePopulation estimates of the prevalence of medication use, concurrent use, and potential major drug-drug interactions, stratified by age group and gender.

resultsThe unweighted survey response rate was 74.8% (weighted response rate, 75.5%). Eighty-one percent (95% confidence interval [CI], 79.4%-83.5%) used at least 1 prescription medication, 42% (95% CI, 39.7%-44.8%) used at least 1 over-the-counter medication, and 49% (95% CI, 46.2%-52.7%) used a dietary supplement. Twenty-nine percent (95% CI, 26.6%-30.6%) used at least 5 prescription medications concurrently; this was highest among men (37.1%; 95% CI, 31.7%-42.4%) and women (36.0%; 95% CI, 30.2%-41.9%) aged 75 to 85 years. Among prescription medication users, concurrent use of over-the-counter medications was 46% (95% CI, 43.4%-49.1%) and concurrent use of dietary supplements was 52% (95% CI, 48.8%-55.5%). Overall, 4% of individuals were potentially at risk of having a major drug-drug interaction; half of these involved the use of nonprescription medications. These regimens were most prevalent among men in the oldest age group (10%; 95% CI, 6.4%-13.7%) and nearly half involved anticoagulants. No contraindicated concurrent drug use was identified.

conclusionsIn this sample of community-dwelling older adults, prescription and nonprescription medications were commonly used together, with nearly 1 in 25 individuals potentially at risk for a major drug-drug interaction.

Indexed as

Nonprescription DrugsPrescription DrugsAgedAged, 80 and overComorbidityDietary SupplementsDrug InteractionsDrug UtilizationFemaleHealth StatusHealth SurveysHumansMaleMiddle AgedRiskSocioeconomic FactorsNonprescription DrugsPrescription Drugs

Identifiers

PMID19109115
PMCPMC2702513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.